Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

EBS

Emergent Biosolutions Inc

May 02 • 04:00PM ET

3.30

Dollar change +1.37
Percentage change 70.98	%

Healthcare • Drug Manufacturers - Specialty & Generic • USA • NYSE

Stock Detail • Compare Perf. • Revenue • Options Chain • Save to Portfolio • Create Alert

Held by: FNDA VTI IWM VXF PRFZ IWN AVUV VTWO SCHA VHT

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-11.02	Insider Own	4.05%	Shs Outstand	52.20M	Perf Week	69.23%
Market Cap	172.26M	Forward P/E	-	EPS next Y	-1.15	Insider Trans	0.00%	Shs Float	50.09M	Perf Month	46.02%
Income	-565.20M	PEG	-	EPS next Q	-0.94	Inst Own	78.29%	Short Float	11.77%	Perf Quarter	100.00%
Sales	1.19B	P/S	0.15	EPS this Y	80.42%	Inst Trans	-1.89%	Short Ratio	1.92	Perf Half Y	57.89%
Book/sh	12.67	P/B	0.26	EPS next Y	5.74%	ROA	-23.78%	Short Interest	5.89M	Perf Year	-60.10%
Cash/sh	1.51	P/C	2.18	EPS next 5Y	-	ROE	-60.56%	52W Range	1.42 - 10.88	Perf YTD	37.50%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-	ROI	-50.89%	52W High	-69.67%	Beta	1.19
Dividend TTM	-	Quick Ratio	0.55	Sales past 5Y	10.59%	Gross Margin	36.74%	52W Low	132.39%	ATR (14)	0.37
Dividend Ex-Date	-	Current Ratio	1.08	EPS Y/Y TTM	-36.83%	Oper. Margin	0.67%	RSI (14)	73.23	Volatility	18.89% 10.72%
Employees	1600	Debt/Eq	1.36	Sales Y/Y TTM	21.14%	Profit Margin	-47.68%	Recom	3.00	Target Price	5.00
Option/Short	Yes / Yes	LT Debt/Eq	0.67	EPS Q/Q	104.73%	Payout	-	Rel Volume	49.34	Prev Close	1.93
Sales Surprise	36.39%	EPS Surprise	160.20%	Sales Q/Q	81.95%	Earnings	May 01 AMC	Avg Volume	3.06M	Price	3.30
SMA20	58.65%	SMA50	34.77%	SMA200	8.09%	Trades		Volume	151,130,795	Change	70.98%

Date	Action	Analyst	Rating Change	Price Target Change
Mar-07-24	Upgrade	The Benchmark Company	Hold → Buy	$5
Nov-20-23	Resumed	JP Morgan	Underweight
Aug-29-23	Downgrade	The Benchmark Company	Buy → Hold
Apr-10-23	Upgrade	The Benchmark Company	Hold → Buy	$22
Mar-17-23	Downgrade	JP Morgan	Neutral → Underweight	$23 → $9
Nov-10-22	Downgrade	The Benchmark Company	Buy → Hold
Apr-29-22	Downgrade	Cantor Fitzgerald	Overweight → Neutral
Jan-20-22	Upgrade	The Benchmark Company	Hold → Buy	$77
Nov-08-21	Downgrade	The Benchmark Company	Buy → Hold
May-05-21	Downgrade	Argus	Buy → Hold
Apr-07-21	Initiated	The Benchmark Company	Buy	$150
Feb-24-21	Upgrade	Chardan Capital Markets	Neutral → Buy	$112
Feb-19-21	Downgrade	Chardan Capital Markets	Buy → Neutral	$112
Jan-08-21	Downgrade	Wells Fargo	Overweight → Equal Weight	$110
Sep-14-20	Resumed	JP Morgan	Neutral	$103
Jul-31-20	Reiterated	Chardan Capital Markets	Buy	$86 → $112
Sep-12-19	Initiated	Guggenheim	Buy
Sep-04-19	Upgrade	Wells Fargo	Market Perform → Outperform
Nov-02-18	Upgrade	Goldman	Neutral → Buy
Aug-03-18	Reiterated	Chardan Capital Markets	Buy	$53 → $57

Show Previous Ratings

May-02-24 01:48PM	Top Midday Gainers (MT Newswires) +70.98%
12:33PM	Q1 2024 Emergent BioSolutions Inc Earnings Call (Thomson Reuters StreetEvents)
12:10PM	MercadoLibre Stock Split: Will MELI Investors See Wishes Come True Today? (InvestorPlace)
11:27AM	JPMorgan Just Raised Its Price Target on Carvana (CVNA) Stock (InvestorPlace)
11:13AM	Emergent BioSolutions Layoffs 2024: What to Know About the Latest EBS Job Cuts (InvestorPlace)
10:38AM	Loading…
10:38AM	Emergent BioSolutions Inc. (NYSE:EBS) Q1 2024 Earnings Call Transcript (Insider Monkey)
08:00AM	Top Premarket Gainers (MT Newswires)
07:58AM	Why Is Emergent BioSolutions (EBS) Stock Up 57% Today? (InvestorPlace)
07:37AM	Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday (InvestorPlace)
03:54AM	Emergent BioSolutions Inc (EBS) (Q1 2024) Earnings Call Transcript Highlights: A Strong Start ... (GuruFocus.com)
12:42AM	PRESS DIGEST- Wall Street Journal - May 2 (Reuters)
May-01-24 11:45PM	Emergent BioSolutions (EBS) Q1 2024 Earnings Call Transcript (Motley Fool)
10:56PM	EBS Stock Earnings: Emergent BioSolutions Beats EPS, Beats Revenue for Q1 2024 (InvestorPlace)
06:15PM	Emergent BioSolutions Reports Surprising Q1 2024 Earnings, Exceeding Revenue and Net Income ... (GuruFocus.com)
05:53PM	Emergent Biosolutions: Q1 Earnings Snapshot (Associated Press Finance)
05:52PM	Loading…
05:52PM	Narcan-Maker Emergent BioSolutions to Cut 300 Jobs, Close Facilities (The Wall Street Journal)
04:57PM	Emergent BioSolutions Reports First Quarter 2024 Financial Results (GlobeNewswire)
04:34PM	UPDATE 2-Emergent BioSolutions to lay off about 300 employees (Reuters)
04:21PM	Emergent BioSolutions to cut 300 jobs (Reuters)
04:10PM	Emergent BioSolutions Announces Strategic Operational Changes to Stabilize Financial Position (GlobeNewswire)
11:03AM	Emergent BioSolutions Releases New Survey Findings Underscoring the Need to Continue Expanding Access & Increasing Awareness to Naloxone (GlobeNewswire)
Apr-30-24 05:26PM	Emergent BioSolutions Announces Amendment to its Existing Credit Facility (GlobeNewswire)
Apr-22-24 08:05AM	Emergent BioSolutions to Release First Quarter 2024 Financial Results & Conduct Conference Call on May 1, 2024 (GlobeNewswire) +5.88%
Apr-01-24 08:00AM	Aquestive Therapeutics Strengthens Board of Directors with Experienced Biotech Executive (GlobeNewswire) -9.09%
Mar-28-24 08:15AM	Emergent BioSolutions Continues to Broaden Access, Awareness and Availability of NARCAN Nasal Spray to Help Save Lives from the Ongoing Opioid Crisis (GlobeNewswire)
Mar-25-24 08:05AM	Emergent BioSolutions Receives NAI Status for Baltimore Bayview Manufacturing Facility (GlobeNewswire) +5.39%
Mar-07-24 01:58PM	Emergent BioSolutions Inc (EBS) Reports Mixed Fourth Quarter and Full Year 2023 Financial Results (GuruFocus.com) -15.03%
12:34PM	Emergent (EBS) Down 16% on Q4 Earnings Miss, Tops on Sales (Zacks)
10:33AM	Emergent BioSolutions Inc. (NYSE:EBS) Q4 2023 Earnings Call Transcript (Insider Monkey)
07:35AM	Q4 2023 Emergent BioSolutions Inc Earnings Call (Thomson Reuters StreetEvents)
11:30PM	Loading…
Mar-06-24 11:30PM	Emergent BioSolutions (EBS) Q4 2023 Earnings Call Transcript (Motley Fool)
09:53PM	EBS Stock Earnings: Emergent BioSolutions Misses EPS, Misses Revenue for Q4 2023 (InvestorPlace)
05:55PM	Emergent Biosolutions (EBS) Reports Q4 Loss, Tops Revenue Estimates (Zacks)
05:20PM	Emergent Biosolutions: Q4 Earnings Snapshot (Associated Press Finance)
04:31PM	Emergent BioSolutions Reports Fourth Quarter 2023 Financial Results (GlobeNewswire)
Feb-29-24 07:00AM	Emergent BioSolutions to Release Fourth Quarter & Full Year 2023 Financial Results, and Conduct Conference Call on March 6, 2024 (GlobeNewswire)
Feb-21-24 03:24PM	Why Is Emergent BioSolutions (EBS) Stock Up 70% Today? (InvestorPlace) +78.29%
07:35AM	UPDATE 2-Emergent appoints former Bausch + Lomb CEO to head company (Reuters)
07:06AM	Emergent names Joseph Papa as new CEO (Reuters)
07:00AM	Emergent BioSolutions Appoints Industry Leader Joseph C. Papa as New President and CEO (GlobeNewswire)
Jan-17-24 11:55AM	Emergent extends shelf life of opioid overdose reversal drug Narcan (Reuters) -5.42%
Jan-12-24 02:20PM	Emergent (EBS) Gets $235.8M DoD Contract for Anthrax Vaccine (Zacks)
Jan-11-24 08:00AM	Emergent BioSolutions Awarded Procurement Contract Valued up to $235.8 Million to Supply BioThrax (Anthrax Vaccine Adsorbed) to the U.S. Department of Defense (GlobeNewswire)
Jan-09-24 07:30AM	Emergent BioSolutions to Present at the 42nd Annual J.P. Morgan Healthcare Conference on January 11, 2024 (GlobeNewswire)
Dec-12-23 06:53AM	EBS Stock Earnings: Emergent BioSolutions Misses EPS, Beats Revenue for Q3 2023 (InvestorPlace)
Dec-11-23 10:05AM	Emergent Biosolutions (EBS) Reports Q3 Loss, Tops Revenue Estimates (Zacks) -14.86%
09:03AM	Emergent Biosolutions: Q3 Earnings Snapshot (Associated Press Finance)
Nov-29-23 11:56AM	Emergent (EBS) Gets $75M BARDA Contract for Anthrax Vaccine (Zacks) +6.97%
Nov-28-23 06:59AM	Emergent BioSolutions Receives $75 Million Contract Option from BARDA to Procure Doses of CYFENDUS (Anthrax Vaccine Adsorbed, Adjuvanted) (GlobeNewswire)
Nov-24-23 07:30AM	Emergent BioSolutions Receives NYSE Notice Regarding Delayed Form 10-Q Filing (GlobeNewswire)
Nov-09-23 01:19PM	Emergent BioSolutions Inc. (NYSE:EBS) Q3 2023 Earnings Call Transcript (Insider Monkey)
Nov-08-23 11:00PM	Emergent BioSolutions (EBS) Q3 2023 Earnings Call Transcript (Motley Fool) -6.36%
05:38PM	Emergent BioSolutions Reports Third Quarter 2023 Financial Results (GlobeNewswire)
Oct-30-23 04:45PM	UPDATE: Emergent BioSolutions to Release Third Quarter 2023 Financial Results and Conduct Conference Call on November 8, 2023 (GlobeNewswire)
Oct-19-23 06:30AM	Emergent BioSolutions to Release Third Quarter 2023 Financial Results and Conduct Conference Call on November 2, 2023 (GlobeNewswire)
Oct-16-23 07:00AM	Emergent BioSolutions Partners with Emmitt Smith to Launch Ready to Rescue Campaign to Help Save Lives Amidst Rising Opioid Epidemic (PR Newswire)
Oct-02-23 07:00AM	Emergent BioSolutions Names Two Pharmaceutical Industry Veterans to Board of Directors (GlobeNewswire) -7.06%
Sep-07-23 11:30AM	Why Is Emergent Biosolutions (EBS) Down 22.6% Since Last Earnings Report? (Zacks)
Aug-30-23 05:59AM	Emergent BioSolutions NARCAN® Nasal Spray Launches Over the Counter Making it Possible for Everyone to Help Save a Life from an Opioid Overdose Emergency (GlobeNewswire) +11.55%
Aug-29-23 09:37AM	Oracle upgraded, Farfetch downgraded: Wall Street's top analyst calls (The Fly) -7.92%
Aug-25-23 11:36AM	Emergent BioSolutions (EBS) Down 12% in a Week: Here's Why (Zacks)
Aug-23-23 12:33PM	Moody's downgrades Emergent BioSolutions' credit rating, citing unpredictable revenue outlook (American City Business Journals)
Aug-22-23 11:42AM	Why Emergent BioSolutions Stock Is Tumbling Today (Motley Fool) -5.88%
Aug-21-23 06:00PM	Kenvue Set to Join S&P 500; Advance Auto Parts to Join S&P SmallCap 600 (PR Newswire)
Aug-17-23 09:57AM	Sonnet (SONN) Up as Ovarian Cancer Drug Enters Clinical Study (Zacks)
09:35AM	Down -28.45% in 4 Weeks, Here's Why You Should You Buy the Dip in Emergent Biosolutions (EBS) (Zacks)
Aug-16-23 09:35AM	Down -26.38% in 4 Weeks, Here's Why You Should You Buy the Dip in Emergent Biosolutions (EBS) (Zacks)
Aug-09-23 09:26AM	Emergent (EBS) Q2 Earnings Miss Estimates, Revenues Beat (Zacks) -17.78%
08:29AM	Q2 2023 Emergent BioSolutions Inc Earnings Call (Thomson Reuters StreetEvents)
12:30AM	Emergent BioSolutions (EBS) Q2 2023 Earnings Call Transcript (Motley Fool)
Aug-08-23 07:40PM	Emergent Biosolutions (EBS) Reports Q2 Loss, Tops Revenue Estimates (Zacks)
06:29PM	Emergent Biosolutions: Q2 Earnings Snapshot (AP Finance)
04:31PM	Emergent BioSolutions Reports Financial Results for Second Quarter 2023 (GlobeNewswire)
08:23AM	Emergent BioSolutions to lay off 400 as its scales back its contract manufacturing business (American City Business Journals)
07:50AM	Emergent BioSolutions to lay off about 400 employees (Reuters)
07:44AM	UPDATE 1-Emergent BioSolutions to lay off about 400 employees (Reuters)
07:15AM	Emergent BioSolutions Announces Strategic Steps to Strengthen Core Business and Financial Position (GlobeNewswire)
Aug-07-23 11:32AM	Drug, Biotech Stocks' Q2 Earnings on Aug 8: LLY, LGND & More (Zacks)
Aug-04-23 09:21AM	4 Biotech Stocks Set to Outpace Q2 Earnings Estimates (Zacks)
Aug-01-23 12:06PM	Gaithersburg's Emergent BioSolutions lands large federal contract to boost development of Ebola drug (American City Business Journals) +14.97%
Jul-31-23 04:05PM	Emergent BioSolutions Awarded 10-Year BARDA Contract Valued at up to a Maximum of $704 Million for Advanced Development and Procurement of Ebanga Treatment for Ebola (GlobeNewswire)
Jul-25-23 06:30AM	Emergent BioSolutions to Release Second Quarter 2023 Financial Results and Conduct Conference Call on August 8, 2023 (GlobeNewswire)
Jul-20-23 06:31PM	UPDATE 1-US FDA approves Emergent BioSolutions' anthrax vaccine (Reuters)
06:15PM	US FDA approves Emergent BioSolutions' anthrax vaccine (Reuters)
06:03PM	Emergent BioSolutions Receives U.S. FDA Approval of CYFENDUS (Anthrax Vaccine Adsorbed, Adjuvanted), previously known as AV7909, a Two-Dose Anthrax Vaccine for Post-Exposure Prophylaxis Use (GlobeNewswire)
Jun-27-23 05:30PM	Why Emergent BioSolutions Stock Dived by 9% Today (Motley Fool) -8.95%
08:02AM	Emergent BioSolutions CEO Robert Kramer to retire immediately (Reuters)
07:55AM	Emergent BioSolutions Announces CEO Transition (GlobeNewswire)
Jun-26-23 05:30AM	Better Recovery-Story Buy: Emergent BioSolutions or Invitae? (Motley Fool)
Jun-21-23 08:00PM	EBS: Raising target price to $8.00 (Argus Research)
11:30AM	Immunovant, Inc. (IMVT) Down 10.6% Since Last Earnings Report: Can It Rebound? (Zacks)
Jun-09-23 08:20AM	Is Emergent BioSolutions Stock a Buy Now? (Motley Fool)
Jun-08-23 11:30AM	Why Is Emergent Biosolutions (EBS) Down 21.4% Since Last Earnings Report? (Zacks)
Jun-07-23 08:20AM	Down 75%, Can Emergent BioSolutions Turn Things Around? (Motley Fool) +6.12%
Jun-05-23 09:39AM	Shareholders in Emergent BioSolutions (NYSE:EBS) are in the red if they invested three years ago (Simply Wall St.)
May-17-23 06:21AM	New Strong Sell Stocks for May 17th (Zacks)
May-15-23 06:27PM	Why Emergent BioSolutions Stock Inched Slightly Higher Today (Motley Fool)
07:58AM	Emergent BioSolutions Finalizes Sale of Travel Health Business to Bavarian Nordic (GlobeNewswire)
May-11-23 06:30AM	Emergent BioSolutions to Hold Virtual Annual Meeting of Stockholders on Thursday, May 25, 2023 at 9:00am EDT (GlobeNewswire)
May-10-23 10:47AM	Emergent (EBS) Q1 Earnings Miss Estimates, Revenues Beat (Zacks) +11.44%

Emergent BioSolutions Inc. engages in the development, manufacture, and commercialization of medical countermeasures. It offers products for civilian and military populations that address accidental, intentional, and naturally occurring public health threats. The firm's products include ACAM2000, BioThrax, Raxibacuma, Vaxchora, and VIGIV. Its business units include Vaccines and Anti-Infectives, Antibody Therapeutics, Devices, and Contract Development and Manufacturing. The company was founded by Fuad El-Hibri on September 5, 1998 and is headquartered in Gaithersburg, MD.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Zoon Kathryn C	Director	Jun 02 '23	Sale	8.35	1,830	15,280	49,971	Jul 24 08:28 AM
Zoon Kathryn C	Director	May 25 '23	Sale	8.38	1,700	14,246	51,801	Jul 24 08:28 AM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

EBS

Emergent Biosolutions Inc

Upgrade your FINVIZ experience